drugset / Trial / NCT02424578

Study of Diclofenac Capsules to Treat Pain Following Surgery in Children Ages 6 to <17 Years of Age

NCT02424578

Phase 2 Completed 30 enrolled Iroko Pharmaceuticals, LLC
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purposes of this study are to evaluate the safety and tolerability and to model the single-dose pharmacokinetic profile of diclofenac capsules low dose and high dose in children ages 6 to \<17 years experiencing mild to moderate acute postoperative pain.

Timeline

Start
2015-05
Primary completion
2016-04
Completion
2016-04-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac Other / unclassified

Indications

No indication recorded.